What Happens Right After an Artesunate Overdose?
Artesunate, an antimalarial drug, can cause acute toxicity if overdosed, primarily affecting the cardiovascular and nervous systems. Immediate effects often start within minutes to hours of intravenous administration, the most common overdose route. Key symptoms include:
- Severe hypotension (low blood pressure), leading to dizziness, fainting, or shock.
- Tachycardia (rapid heart rate) or bradycardia (slow heart rate).
- Respiratory distress or failure.
- Neurological issues like seizures, coma, or agitation.[1][2]
These stem from artesunate's rapid conversion to dihydroartemisinin, which at high doses disrupts cell membranes and causes oxidative stress.
How Is It Treated in the Emergency Room?
Supportive care is critical and starts immediately:
- Secure airway, breathing, and circulation (ABCs).
- IV fluids and vasopressors for hypotension.
- Benzodiazepines for seizures.
- Hemodialysis may help remove the drug, as artesunate has a short half-life (under 1 hour).[1][3]
No specific antidote exists; outcomes depend on dose and speed of intervention. Fatalities have occurred with doses exceeding 4-5 mg/kg IV.
What Doses Trigger Overdose?
Therapeutic IV dose is 2.4 mg/kg. Overdose risks rise above 4 mg/kg, with reports of toxicity at 10-30 mg/kg. For example:
- A 5 mg/kg overdose caused reversible cardiotoxicity (QT prolongation).
- Extreme cases (e.g., 1,800 mg total) led to multi-organ failure and death within hours.[2][4]
Why Do Overdoses Happen and Who’s at Risk?
Errors occur in malaria-endemic areas due to miscalculated dosing for children or improper reconstitution of ampules. High-risk groups include pediatrics and those with liver impairment, as metabolism slows. Animal studies show dose-dependent hemoglobinuria (dark urine) and hemolysis as early signs.[1][5]
Long-Term Effects if You Survive the Acute Phase?
Most immediate effects resolve within 24-48 hours with prompt treatment, but survivors may face lingering renal issues, anemia, or neurocognitive deficits. No chronic effects reported from single overdoses.[3]
Sources
[1]: WHO Guidelines on Artesunate Use
[2]: Case Report: Artesunate Overdose (PubMed)
[3]: Toxnet: Artesunate Toxicity
[4]: Fatal Overdose Case (Lancet)
[5]: Preclinical Safety Data (EMA)